Patient Preference Top Reason For Switching Back To Natalizumab From Ocrelizumab: A Relapsing Multiple Sclerosis Patient Case SeriesC. Kutz, A. Gocke,R. Avila, D. RutledgeMULTIPLE SCLEROSIS JOURNAL(2021)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要